BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36921674)

  • 21. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
    Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
    Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor Progression.
    Wei Y; Zhang J; Fan X; Zheng Z; Jiang X; Chen D; Lu Y; Li Y; Wang M; Hu M; Du Q; Yang L; Li H; Xiao Y; Li Y; Jin J; Wang D; Yuan X; Li Q
    Front Immunol; 2022; 13():935552. PubMed ID: 35874784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
    Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
    J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer.
    Jeong SH; Park M; Park SY; Park J; Kim TH; Lee YJ; Jung EJ; Ju YT; Jeong CY; Kim JY; Ko GH; Kim M; Nam KT; Goldenring JR
    Technol Cancer Res Treat; 2021; 20():15330338211019501. PubMed ID: 34060350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment.
    Wu S; Huang H; Sun R; Gao DS; Ye F; Huang J; Li E; Ni A; Lu KG; Chen K; Jiang J; Morel PA; Zhong Z; Lu B
    Cancer Res Commun; 2023 Aug; 3(8):1460-1472. PubMed ID: 37546701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral PD-1
    Yu K; Gu Y; Zhang P; Fang H; Cao Y; Wang J; Lin C; Liu H; Zhang H; He H; Li R; Qin J; Li H; Xu J
    Br J Cancer; 2022 Nov; 127(9):1709-1717. PubMed ID: 36002752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis.
    Xing X; Shi J; Jia Y; Dou Y; Li Z; Dong B; Guo T; Cheng X; Li X; Du H; Hu Y; Jia S; Zhang J; Li Z; Ji J
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35361730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review.
    Bos J; Groen-van Schooten TS; Brugman CP; Jamaludin FS; van Laarhoven HWM; Derks S
    Cancer Treat Rev; 2024 Jun; 127():102737. PubMed ID: 38669788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
    Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
    Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer.
    Park HS; Kim YM; Kim S; Lee WS; Kong SJ; Yang H; Kang B; Cheon J; Shin SJ; Kim C; Chon HJ
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34670828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites.
    Muijlwijk T; Nijenhuis DNLM; Ganzevles SH; Brink A; Ke C; Fass JN; Rajamanickam V; Leemans CR; Koguchi Y; Fox BA; Poell JB; Brakenhoff RH; van de Ven R
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
    O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
    Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
    Konno-Shimizu M; Yamamichi N; Inada K; Kageyama-Yahara N; Shiogama K; Takahashi Y; Asada-Hirayama I; Yamamichi-Nishina M; Nakayama C; Ono S; Kodashima S; Fujishiro M; Tsutsumi Y; Ichinose M; Koike K
    PLoS One; 2013; 8(2):e56766. PubMed ID: 23451082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer.
    Li FQ; Xu B; Wu YJ; Yang ZL; Qian JJ
    Genet Mol Res; 2015 Jan; 14(1):739-47. PubMed ID: 25730011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database.
    Nie D; Zheng H; An G; Li J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8593-8603. PubMed ID: 37097391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
    Ding L; Sun L; Bu MT; Zhang Y; Scott LN; Prins RM; Su MA; Lechner MG; Hugo W
    Front Immunol; 2023; 14():1176994. PubMed ID: 37435085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune infiltration profiling in gastric cancer and their clinical implications.
    Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
    Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of tertiary lymphoid structures-related genes for prognostic prediction, molecular subtypes and immune infiltration in gastric cancer.
    Zhou Q; Lan L; Wang W; Xu X; Wang W
    Aging (Albany NY); 2023 Nov; 15(22):13368-13383. PubMed ID: 38015717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.